Here's a summary of some of the oral drugs in the pipeline.
Is an Oral Disease-Modifying Drug on the Horizon? 14 February 2006
For over a decade now, we have had the benefit of PDA-approved disease-modifying drugs: the beta interferons (Betaseron, Avonex, and Rebif), glatiramer acetate (Copaxone), and, more recently, mitoxantrone (Novantrone). All are injected-under the skin, into muscle, or into a vein. Natalizumab (Tysabri), which is currently under a new FDA review, is also ...
Read more : Oral drugs
| Views :
1173 | Replies :